Global Lung-on-a-chip 麻豆原创 Research Report 2023

Publication ID:

PB502238356

Publication Date:

February 8, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Hardware (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

尝耻苍驳听辞苍听补听肠丑颈辫.听罢丑别听诲别惫颈肠别听颈蝉听尘补诲别听耻蝉颈苍驳听丑耻尘补苍听濒耻苍驳听补苍诲听产濒辞辞诲听惫别蝉蝉别濒听肠别濒濒蝉听补苍诲听颈迟听肠补苍听辫谤别诲颈肠迟听补产蝉辞谤辫迟颈辞苍听辞蹿听补颈谤产辞谤苍别听苍补苍辞辫补谤迟颈肠濒别蝉听补苍诲听尘颈尘颈肠听迟丑别听颈苍蹿濒补尘尘补迟辞谤测听谤别蝉辫辞苍蝉别听迟谤颈驳驳别谤别诲听产测听尘颈肠谤辞产颈补濒听辫补迟丑辞驳别苍蝉.听滨迟听肠补苍听产别听耻蝉别诲听迟辞听迟别蝉迟听迟丑别听别蹿蹿别肠迟蝉听辞蹿听别苍惫颈谤辞苍尘别苍迟补濒听迟辞虫颈苍蝉,听补产蝉辞谤辫迟颈辞苍听辞蹿听补别谤辞蝉辞濒颈锄别诲听迟丑别谤补辫别耻迟颈肠蝉,听补苍诲听迟丑别听蝉补蹿别迟测听补苍诲听别蹿蹿颈肠补肠测听辞蹿听苍别飞听诲谤耻驳蝉.
Highlights
The global Lung-on-a-chip market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Lung-on-a-chip is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Lung-on-a-chip is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Lung-on-a-chip in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Lung-on-a-chip include Emulate, Tissuse, Hesperos, CN Bio Innovations, Draper Laboratory, Mimetas, Nortis, Kirkstall and Cherry Biotech SAS, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lung-on-a-chip, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung-on-a-chip.
The Lung-on-a-chip market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Lung-on-a-chip market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung-on-a-chip companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Micronit Microtechnologies B.V.
Segment by Type
Pulmonary Inflammation
Pulmonary Infection
Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung-on-a-chip companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Lung-on-a-chip 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Pulmonary Inflammation
1.2.3 Pulmonary Infection
1.3 麻豆原创 by Application
1.3.1 Global Lung-on-a-chip 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung-on-a-chip 麻豆原创 Perspective (2018-2029)
2.2 Lung-on-a-chip Growth Trends by Region
2.2.1 Global Lung-on-a-chip 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Lung-on-a-chip Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Lung-on-a-chip Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Lung-on-a-chip 麻豆原创 Dynamics
2.3.1 Lung-on-a-chip Industry Trends
2.3.2 Lung-on-a-chip 麻豆原创 Drivers
2.3.3 Lung-on-a-chip 麻豆原创 Challenges
2.3.4 Lung-on-a-chip 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung-on-a-chip Players by Revenue
3.1.1 Global Top Lung-on-a-chip Players by Revenue (2018-2023)
3.1.2 Global Lung-on-a-chip Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Lung-on-a-chip 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lung-on-a-chip Revenue
3.4 Global Lung-on-a-chip 麻豆原创 Concentration Ratio
3.4.1 Global Lung-on-a-chip 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung-on-a-chip Revenue in 2022
3.5 Lung-on-a-chip Key Players Head office and Area Served
3.6 Key Players Lung-on-a-chip Product Solution and Service
3.7 Date of Enter into Lung-on-a-chip 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung-on-a-chip Breakdown Data by Type
4.1 Global Lung-on-a-chip Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Lung-on-a-chip Forecasted 麻豆原创 Size by Type (2024-2029)
5 Lung-on-a-chip Breakdown Data by Application
5.1 Global Lung-on-a-chip Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Lung-on-a-chip Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Lung-on-a-chip 麻豆原创 Size (2018-2029)
6.2 North America Lung-on-a-chip 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Lung-on-a-chip 麻豆原创 Size by Country (2018-2023)
6.4 North America Lung-on-a-chip 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung-on-a-chip 麻豆原创 Size (2018-2029)
7.2 Europe Lung-on-a-chip 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Lung-on-a-chip 麻豆原创 Size by Country (2018-2023)
7.4 Europe Lung-on-a-chip 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung-on-a-chip 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Lung-on-a-chip 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Lung-on-a-chip 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Lung-on-a-chip 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lung-on-a-chip 麻豆原创 Size (2018-2029)
9.2 Latin America Lung-on-a-chip 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Lung-on-a-chip 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Lung-on-a-chip 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung-on-a-chip 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Lung-on-a-chip 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Lung-on-a-chip 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Lung-on-a-chip 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Detail
11.1.2 Emulate Business Overview
11.1.3 Emulate Lung-on-a-chip Introduction
11.1.4 Emulate Revenue in Lung-on-a-chip Business (2018-2023)
11.1.5 Emulate Recent Development
11.2 Tissuse
11.2.1 Tissuse Company Detail
11.2.2 Tissuse Business Overview
11.2.3 Tissuse Lung-on-a-chip Introduction
11.2.4 Tissuse Revenue in Lung-on-a-chip Business (2018-2023)
11.2.5 Tissuse Recent Development
11.3 Hesperos
11.3.1 Hesperos Company Detail
11.3.2 Hesperos Business Overview
11.3.3 Hesperos Lung-on-a-chip Introduction
11.3.4 Hesperos Revenue in Lung-on-a-chip Business (2018-2023)
11.3.5 Hesperos Recent Development
11.4 CN Bio Innovations
11.4.1 CN Bio Innovations Company Detail
11.4.2 CN Bio Innovations Business Overview
11.4.3 CN Bio Innovations Lung-on-a-chip Introduction
11.4.4 CN Bio Innovations Revenue in Lung-on-a-chip Business (2018-2023)
11.4.5 CN Bio Innovations Recent Development
11.5 Draper Laboratory
11.5.1 Draper Laboratory Company Detail
11.5.2 Draper Laboratory Business Overview
11.5.3 Draper Laboratory Lung-on-a-chip Introduction
11.5.4 Draper Laboratory Revenue in Lung-on-a-chip Business (2018-2023)
11.5.5 Draper Laboratory Recent Development
11.6 Mimetas
11.6.1 Mimetas Company Detail
11.6.2 Mimetas Business Overview
11.6.3 Mimetas Lung-on-a-chip Introduction
11.6.4 Mimetas Revenue in Lung-on-a-chip Business (2018-2023)
11.6.5 Mimetas Recent Development
11.7 Nortis
11.7.1 Nortis Company Detail
11.7.2 Nortis Business Overview
11.7.3 Nortis Lung-on-a-chip Introduction
11.7.4 Nortis Revenue in Lung-on-a-chip Business (2018-2023)
11.7.5 Nortis Recent Development
11.8 Kirkstall
11.8.1 Kirkstall Company Detail
11.8.2 Kirkstall Business Overview
11.8.3 Kirkstall Lung-on-a-chip Introduction
11.8.4 Kirkstall Revenue in Lung-on-a-chip Business (2018-2023)
11.8.5 Kirkstall Recent Development
11.9 Cherry Biotech SAS
11.9.1 Cherry Biotech SAS Company Detail
11.9.2 Cherry Biotech SAS Business Overview
11.9.3 Cherry Biotech SAS Lung-on-a-chip Introduction
11.9.4 Cherry Biotech SAS Revenue in Lung-on-a-chip Business (2018-2023)
11.9.5 Cherry Biotech SAS Recent Development
11.10 Else Else Kooi Laboratory
11.10.1 Else Else Kooi Laboratory Company Detail
11.10.2 Else Else Kooi Laboratory Business Overview
11.10.3 Else Else Kooi Laboratory Lung-on-a-chip Introduction
11.10.4 Else Else Kooi Laboratory Revenue in Lung-on-a-chip Business (2018-2023)
11.10.5 Else Else Kooi Laboratory Recent Development
11.11 Micronit Microtechnologies B.V.
11.11.1 Micronit Microtechnologies B.V. Company Detail
11.11.2 Micronit Microtechnologies B.V. Business Overview
11.11.3 Micronit Microtechnologies B.V. Lung-on-a-chip Introduction
11.11.4 Micronit Microtechnologies B.V. Revenue in Lung-on-a-chip Business (2018-2023)
11.11.5 Micronit Microtechnologies B.V. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Micronit Microtechnologies B.V.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.